Education

• MD, Vanderbilt University School of Medicine, Nashville, TN, 1997
• Internship and Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1997-2004
• Research Fellowship in Transplantation Immunology, University of Wisconsin Hospital and Clinics, Madison, WI, 1999-2001
• Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2004-2006
• Chief Administrative Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2006

Clinical Specialties

Dr. Cho is certified by the American Board of Surgery. He specializes in malignancies of the pancreas, liver, biliary tract, and stomach, as well as intraabdominal and retroperitoneal sarcomas.

Dr. Cho provides a wide range of services including Beger Procedure, Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Frey Procedure, Gastrectomy - Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Gastrectomy, Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, (show all). Right Hemihepatectomy, Right / Left Extended Hemihepatectomy (Hepatectomy), Wedge Resection of the Liver, and Whipple Procedure.

Research Interests

Dr. Cho conducts basic scientific research in the area of tumor immunology, investigating mechanisms by which tumors evade the host immune response.

Dr. Cho's Lab

Funding/Grants

• T Cell Homeostasis and Melanoma
  Funding Agency: Department of Veterans Affairs - Career Development Award (CDA-2)
  Principal Investigator(s): Clifford S Cho, MD
  More Information

Active Clinical Trials

• A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas (Algenpantucel-L) Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer
  Principal Investigator(s): Clifford S Cho, MD
  Status: Recruiting
  [ClinicalTrials.gov: NCT01072981]
  More Information

Recent Publications

• Melanoma-induced suppression of tumor antigen-specific T cell expansion is comparable to suppression of global T cell expansion.
  Russ AJ, Xu K, Wentworth L, Alam S, Meyers JV, Macklin MD, Rakhmilevich AL, Rajamanickam V, Suresh M, Cho CS
  Cell. Immunol. 2011; 271(1):104-9.
  [PubMed ID: 21741629]
  More Information
• Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique?
  Cho CS, Kooby DA, Schmidt CM, Nakeeb A, Bentrem DJ, Merchant NB, Parikh AA, Martin RC, Scoggins CR, Ahmad SA, Kim HJ, Hamilton N, Hawkins WG, Weber SM
  Ann. Surg. 2011 May; 253(5):975-80.
  [PubMed ID: 21394014]
  More Information
• Suppression of T-cell expansion by melanoma is exerted on resting cells.
  Russ AJ, Wentworth L, Xu K, Rakhmilevich A, Seroogy CM, Sondel PM, Suresh M, Cho CS
  Ann. Surg. Oncol. 2011 Dec; 18(13):3848-57.
  [PubMed ID: 21465311]
  More Information
• Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.
  Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM
  Ann. Surg. Oncol. 2011 Aug; 18(8):2126-35.
  [PubMed ID: 21336514]
  More Information
• The oncologic significance of postoperative complications after hepatic colorectal metastasectomy: biology, technique, or statistical quirk?
  Cho CS
  J. Surg. Res. 2012 Jan; 172(1):80-2.
  [PubMed ID: 21227464]
  More Information